A cross-species drug-discovery platform to accelerate the identification of lifespan-extending interventions.
Key claim: An integrated high-throughput platform spanning yeast, C. elegans, Drosophila, killifish, and mice screened over 400 compounds and identified multi-species geroprotectors converging on conserved longevity pathways.
Abstract
We develop an integrated, high-throughput platform to evaluate pharmacological lifespan-extending interventions across five model organisms spanning unicellular to mammalian biology including yeast, nematodes, fruit flies, killifish, and mice. By combining automated imaging, miniaturized assays, and deep-learning-based death detection, we evaluate over 400 compounds across thousands of conditions. In S. cerevisiae, a miniaturized PI/flow cytometry CLS assay enables scalable screening and identifies key assay confounders, while in C. elegans and D. melanogaster, compact imaging platforms coupled to YOLO-based detection provide a no-transfer, high-throughput survival scoring, and capture compound-, diet-, and sex-dependent effects. In killifish, we develop an in-house drug-pellet formulation for standardized oral delivery in large cohorts, and in mice we combine longitudinal lifespan studies with home-cage activity monitoring to assess late-life interventions. Cross-species integration identifies multi-species geroprotectors and reveals convergence on known and novel conserved longevity pathways, illustrating how this scalable framework can prioritize interventions with high translational potential.
Why this matters
Most trending longevity compounds in this area (rapamycin, peptides, ketones, natural GLP-1 mimetics) reach consumers via mechanism claims and single-model animal data. A cross-species screening platform is a methods-level attempt to raise the bar for what counts as a prioritized geroprotector before it enters the influencer pipeline — the trajectory to watch is whether its eventual hits actually filter into clinics and stacks, or whether the platform’s outputs stay upstream of consumer culture.